Kcl Capital, L.P. Tc Bio Pharm (Holdings) PLC Transaction History

Kcl Capital, L.P.

  • $0
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.34 - $1.67 $34,000 - $167,000
100,000 New
100,000 $37,000

About TC BioPharm (Holdings) plc

TCBP Quotes by TradingView
  • Ticker TCBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,747,700
  • Market Cap $28.2M
  • Description
  • TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19...
More about TCBP
Track This Portfolio

Track Kcl Capital, L.P. Portfolio

Follow Kcl Capital, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcl Capital, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Kcl Capital, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email